These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 14832733)

  • 1. Contribution to the study of the mechanism of action of cholinesterase inhibitors.
    KOPPANYI T; KARCZMAR A
    J Pharmacol Exp Ther; 1951 Apr; 101(4):327-44. PubMed ID: 14832733
    [No Abstract]   [Full Text] [Related]  

  • 2. Site and mode of action of several cholinesterase inhibitors.
    MILLER DS; GINSBURG B
    Fed Proc; 1947; 6(1):358. PubMed ID: 20343748
    [No Abstract]   [Full Text] [Related]  

  • 3. [ON THE PROTECTIVE ACTION OF ACETYLCHOLINE IN THE INTERACTION OF SERUM CHOLINESTERASE WITH ORGANIC PHOSPHATE INHIBITORS].
    BRESTKIN AP; VOLKOVA RI; ROZENGART EV
    Dokl Akad Nauk SSSR; 1964 Aug; 157():1459-62. PubMed ID: 14273586
    [No Abstract]   [Full Text] [Related]  

  • 4. [ACTION OF MAGNESIUM IONS ON PROTECTION OF CHOLINESTERASES EXERTED BY CERTAIN CHOLINESTERASE ANTAGONISTS WITH A QUATERNARY AMMONIUM FUNCTION RESPECTING THAT OF DFP].
    TAZIEFF-DEPIERRE F; RAPOPORT G; MARTIN L
    C R Hebd Seances Acad Sci; 1965 Jan; 260():730-3. PubMed ID: 14282916
    [No Abstract]   [Full Text] [Related]  

  • 5. The mechanism of action of anticholinesterase drugs.
    BURGEN AS
    Br J Pharmacol Chemother; 1949 Sep; 4(3):219-28. PubMed ID: 18141083
    [No Abstract]   [Full Text] [Related]  

  • 6. [ELECTROPHORETIC RESEARCH ON THE BINDING OF INHIBITORS WITH SERUM CHOLINESTERASE].
    VINCENT D; SEGONZAC G
    Pathol Biol; 1965 Mar; 13():280-4. PubMed ID: 14339151
    [No Abstract]   [Full Text] [Related]  

  • 7. [A possibility for the utilization of a histochemical demonstration of cholinesterase in the study of cholinesterase inhibitors and reactivators].
    POSPISIL M
    Cesk Fysiol; 1960 May; 9():297. PubMed ID: 13737399
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reactivation of phosphorylated cholinesterase immobilized in a gelatin membrane].
    Kugusheva LI; Nikol'skaia EB
    Ukr Biokhim Zh (1978); 1990; 62(2):93-6. PubMed ID: 2368191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal cholinesterase activity: understanding and interpretation.
    Jokanović M; Maksimović M
    Eur J Clin Chem Clin Biochem; 1997 Jan; 35(1):11-6. PubMed ID: 9156559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The "aging" mechanism of cholinesterase depressed by phospho-organic inhibitors].
    Rozengart VI; Balashova EK
    Dokl Akad Nauk SSSR; 1965 Oct; 164(4):937-40. PubMed ID: 5877445
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of cholinesterase inhibitors in vitro and in vivo.
    DuBOIS KP; ERWAY WF; BYERRUM RU
    Fed Proc; 1947; 6(1):326. PubMed ID: 20249571
    [No Abstract]   [Full Text] [Related]  

  • 12. [CLINICAL SIGNIFICANCE OF CHOLINESTERASES].
    KLUGMANN HJ; HAMBSCH K
    Dtsch Gesundheitsw; 1965 Apr; 20():569-74. PubMed ID: 14274235
    [No Abstract]   [Full Text] [Related]  

  • 13. [EXPERIENCES WITH A PROLONGED ACTION CHOLINESTERASE INHIBITOR IN THE TREATMENT OF POSTOPERATIVE INTESTINAL ATONY].
    GERIHAEUSER J
    Wien Klin Wochenschr; 1965 Feb; 77():115-6. PubMed ID: 14259845
    [No Abstract]   [Full Text] [Related]  

  • 14. The mechanism of action of anti-cholinesterases. III. The action of anti-cholinesterases on the phrenic nerve-diaphragm preparation of the rat.
    COHEN JA; POSTHUMUS CH
    Acta Physiol Pharmacol Neerl; 1957 Oct; 5(4):385-97. PubMed ID: 13487337
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative analysis of sensitivity of cholinesterases of various origin to monoonium reversible inhibitors].
    Moralev SN; Rozengart EV
    Zh Evol Biokhim Fiziol; 2007; 43(3):223-39. PubMed ID: 17725026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A RAPID OFFICE CHOLINESTERASE TEST].
    CSOKONAY L; MARTON G
    Orv Hetil; 1964 Oct; 105():2043-4. PubMed ID: 14205789
    [No Abstract]   [Full Text] [Related]  

  • 17. [The reversible inhibition of cholinesterases from different biological sources by phosphonium betaines].
    Zhuzhovskiĭ IuG; Kuznetsova LP; Sochilina EE; Dmitrieva EN; Gololobov IuG; Bykovskaia EIu
    Zh Evol Biokhim Fiziol; 1996; 32(2):212-6. PubMed ID: 8967277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ON THE SIGNIFICANCE OF THE CATION GROUP AND ITS POSITION IN THE MOLECULE FOR THE INTERACTION OF CHOLINESTERASE WITH ITS SUBSTRATES AND REVERSIBLE INHIBITORS].
    FRUENTOV NK
    Biokhimiia; 1963; 28():964-9. PubMed ID: 14188198
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic toxicity of certain anti-cholinesterase drugs.
    KARR NW; PERRY IH
    Fed Proc; 1947; 6(1):343. PubMed ID: 20343714
    [No Abstract]   [Full Text] [Related]  

  • 20. Differentiation of 3 types of competitive cholinesterase inhibitors.
    MYERS DK
    Arch Biochem Biophys; 1951 Mar; 31(1):29-40. PubMed ID: 14820335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.